Necrotizing Fasciitis Caused by ESBL-Producing Raoultella ornithinolytica in an Immunocompromised Patient with VEXAS Syndrome.

IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Moe Sakamoto-Tokunaga, Takayuki Katsuyama, Masaki Matoba, Tomokazu Tamura, Natsuki Kubota, Yuya Terajima, Kenta Shidahara, Kei Hirose, Kazuya Matsumoto, Shoichi Nawachi, Takato Nakadoi, Yu Katayama, Keigo Hayashi, Yoshia Miyawaki, Eri Katsuyama, Haruki Watanabe, Mariko Takano-Narazaki, Yoshinori Matsumoto, Ken-Ei Sada, Shuma Tsuji, Kazuyoshi Gotoh, Shinnosuke Fukushima, Hideharu Hagiya, Jun Wada
{"title":"Necrotizing Fasciitis Caused by ESBL-Producing Raoultella ornithinolytica in an Immunocompromised Patient with VEXAS Syndrome.","authors":"Moe Sakamoto-Tokunaga, Takayuki Katsuyama, Masaki Matoba, Tomokazu Tamura, Natsuki Kubota, Yuya Terajima, Kenta Shidahara, Kei Hirose, Kazuya Matsumoto, Shoichi Nawachi, Takato Nakadoi, Yu Katayama, Keigo Hayashi, Yoshia Miyawaki, Eri Katsuyama, Haruki Watanabe, Mariko Takano-Narazaki, Yoshinori Matsumoto, Ken-Ei Sada, Shuma Tsuji, Kazuyoshi Gotoh, Shinnosuke Fukushima, Hideharu Hagiya, Jun Wada","doi":"10.18926/AMO/70456","DOIUrl":null,"url":null,"abstract":"<p><p>VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory somatic) syndrome has a poor prognosis, with infections being a major cause of death. Raoultella ornithinolytica is an environmental bacterium found predominantly in soil and water. Although R. ornithinolytica can cause various infections, necrotizing fasciitis due to this bacterium has not been reported. We describe the case of an 84-year-old Japanese male with VEXAS syndrome who developed septic shock and necrotizing fasciitis while he was under immunosuppressive therapy. The pathogen was initially misidentified as R. planticola by mass spectrometry but later confirmed by whole-genome sequencing as extended spectrum β-lactamase (ESBL) produced by R. ornithinolytica. Although a life-saving leg amputation was required, the patient recovered with appropriate antibiotic therapy. R. ornithinolytica is thus able to cause severe skin infections in immunocompromised individuals.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"80 2","pages":"141-145"},"PeriodicalIF":0.8000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica Okayama","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18926/AMO/70456","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory somatic) syndrome has a poor prognosis, with infections being a major cause of death. Raoultella ornithinolytica is an environmental bacterium found predominantly in soil and water. Although R. ornithinolytica can cause various infections, necrotizing fasciitis due to this bacterium has not been reported. We describe the case of an 84-year-old Japanese male with VEXAS syndrome who developed septic shock and necrotizing fasciitis while he was under immunosuppressive therapy. The pathogen was initially misidentified as R. planticola by mass spectrometry but later confirmed by whole-genome sequencing as extended spectrum β-lactamase (ESBL) produced by R. ornithinolytica. Although a life-saving leg amputation was required, the patient recovered with appropriate antibiotic therapy. R. ornithinolytica is thus able to cause severe skin infections in immunocompromised individuals.

免疫功能低下的VEXAS综合征患者中产生esbl的鸟嘌呤溶解拉乌尔氏菌引起的坏死性筋膜炎
VEXAS(空泡,E1酶,x -连锁,自身炎症体)综合征预后差,感染是死亡的主要原因。腐鸟拉乌尔菌是一种主要存在于土壤和水中的环境细菌。虽然溶鸟单胞菌可引起各种感染,但由于这种细菌引起的坏死性筋膜炎尚未见报道。我们描述的情况下,84岁的日本男性与VEXAS综合征谁发展感染性休克和坏死性筋膜炎,而他接受免疫抑制治疗。该病原菌最初被质谱鉴定为足底真菌,但后来通过全基因组测序证实是由鸟毒杆菌产生的扩展谱β-内酰胺酶(ESBL)。虽然需要截肢来挽救生命,但患者在适当的抗生素治疗下恢复了健康。因此,在免疫功能低下的个体中,溶鸟鼻虫能够引起严重的皮肤感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta medica Okayama
Acta medica Okayama 医学-医学:研究与实验
CiteScore
1.00
自引率
0.00%
发文量
110
审稿时长
6-12 weeks
期刊介绍: Acta Medica Okayama (AMO) publishes papers relating to all areas of basic and clinical medical science. Papers may be submitted by those not affiliated with Okayama University. Only original papers which have not been published or submitted elsewhere and timely review articles should be submitted. Original papers may be Full-length Articles or Short Communications. Case Reports are considered if they describe significant and substantial new findings. Preliminary observations are not accepted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书